ArticleAfrican health sciences2025
Association between polycystic ovary syndrome and systemic immune inflammation index and other inflammation markers; a case-control study.
Article in African health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Therapeutic potential of harmine in polycystic ovarian syndrome: regulation of TNF-α/IL-6-mediated inflammation, Nrf2/keap-1 signaling, and ovarian steroidogenesis in Sprague-Dawley rats.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Work in progress on infections, reproductive sexual health, education and non-communicable diseases.African health sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: The aim of this study was,to determine the relationship between the systemic immune inflammation index-, which is a new inflammatory marker, and other inflammatory markers in patients with polycystic ovary syndrome. Methods: This case-control study was conducted by exaimining patients who presented at the Gynecology and Obstetrics Outpatient Clinic of Derince Training and Research Hospital between 2018-2022. Inflammatory markers were compared in hemogram parameters of 180 patients with polycystic ovary syndrome and 178 control group subjects. The two groups were compared in respect of hemoglobin(Hb), white blood cell (Wbc), platelet (Plt), neutrophil (Neu), lymphocyte (Ly), red cell distribution width(RDW), main platelet volume (MPV), platelet distribution width (PDW), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR) and systemic immune inflammation index (SII)values. Results: The hemoglobin, white blood cell, platelet, neutrophil, lymphocyte,neutrophil lymphocyte ratio,and systemic immune inflammation index values were determined to be statistically significantly higher in PCOS patients than in the control group. Conclusion: Elevated values of inflammatory markers can be detected in patients with polycystic ovary syndrome,- supporting the presence of inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.